Sprycel May Increase Risk of Pulmonary Arterial Hypertension: FDA
The leukemia drug Sprycel has been linked to a rare form of hypertension that can wear down the heart’s ability to pump blood.
The leukemia drug Sprycel has been linked to a rare form of hypertension that can wear down the heart’s ability to pump blood.
Side effects of Sprycel, a leukemia drug made by Bristol-Myers Squibb, have been linked to an increased risk of pulmonary arterial hypertension (PAH), which can weaken the heart and reduce…